Gainers
Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
B&G Foods, Inc. (NYSE:BGS) announced today that it has entered into an agreement to sell the Back to Nature brand to Barilla America.
"Our decision to sell Back to Nature is part of a